A bit about me
Knowing that my work can help ensure patients have access to life-saving medications is what fuels my drive and energy each morning.
Career highlights
Maud joined the Kintiga BeNeLux team in September 2022 as an intern during her final year of the Pharmaceutical Sciences Master’s program in Drug Development at the KU Leuven. She wrote her Master’s thesis on the implementation of the new EU HTA Regulation in collaboration with Kintiga BeNeLux, resulting in a fundamental understanding of the regulation and the new concepts it introduced, such as Joint Scientific Consultations (JSC) and Joint Clinical Assessments (JCA). This work provided her with a deep understanding of the implications and needs for the pharmaceutical industry with regard to the HTAR.
With dual Master’s degrees in Drug Development and in Management & Policy in Healthcare, Maud brings a strong academic foundation and a focus on market access and healthcare policy. She gained valuable experience working on pricing and reimbursement files (BE and NL), with a particular emphasis on Health Technology Assessments (HTAs). Eager to contribute to the strategic alignment of drug development and market access in this dynamic European environment, Maud is ready to make a meaningful impact.
Expertise
- The new EU HTA regulation policy, processes (JSC and JCA), and methods
- Pricing files Belgium
- Reimbursement Belgium and Netherlands
Personal interests
Outside of work you will probably find me traveling around enjoying good food and wine or hiking in nature.
